Literature DB >> 8186165

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer.

B Glimelius, K Hoffman, U Haglund, O Nyrén, P O Sjödén.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8186165     DOI： 10.1093/oxfordjournals.annonc.a058778

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  73 in total

1.  Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy.

Authors:  Ayumu Hosokawa; Toshiro Sugiyama; Atsushi Ohtsu; Toshihiko Doi; Santa Hattori; Takashi Kojima; Tomonori Yano; Keiko Minashi; Manabu Muto; Shigeaki Yoshida
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

2.  Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer.

Authors:  Manabu Ohashi; Tatsuo Kanda; Masaki Hirota; Takashi Kobayashi; Kazuhito Yajima; Shin-ichi Kosugi; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

3.  Modified Devine exclusion with vertical stomach reconstruction for gastric outlet obstruction: a novel technique.

Authors:  Takatsugu Oida; Kenji Mimatsu; Atsushi Kawasaki; Hisao Kano; Youichi Kuboi; Sadao Amano
Journal:  J Gastrointest Surg       Date:  2009-03-31       Impact factor: 3.452

4.  Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer.

Authors:  Yasunori Emi; Manabu Yamamoto; Ikuo Takahashi; Hiroyuki Orita; Yoshihiro Kakeji; Shunji Kohnoe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

5.  S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.

Authors:  Dan-Hong Li; Zhen-Kui Pan; Feng Ye; Han-Xiang An; Jing-Xun Wu
Journal:  Tumour Biol       Date:  2014-05-22

6.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

7.  Clinical significance of chemotherapy for geriatric patients with advanced or recurrent gastric cancer.

Authors:  Tsutomu Kawaguchi; Shuhei Komatsu; Daisuke Ichikawa; Takeshi Kubota; Kazuma Okamoto; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  Mol Clin Oncol       Date:  2014-10-31

8.  Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).

Authors:  Tomohiro Nishina; Narikazu Boku; Masahiro Gotoh; Yasuhiro Shimada; Yasuo Hamamoto; Hirofumi Yasui; Kensei Yamaguchi; Hiroki Kawai; Norisuke Nakayama; Kenji Amagai; Junki Mizusawa; Kenichi Nakamura; Kuniaki Shirao; Atsushi Ohtsu
Journal:  Gastric Cancer       Date:  2015-09-19       Impact factor: 7.370

9.  The utility and efficacy of self-expandable metal stents for treating malignant gastric outlet obstructions in patients under best supportive care.

Authors:  Yasuki Hori; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Michihiro Yoshida; Yasuaki Fujita; Makoto Natsume; Naruomi Jinno; Akihisa Kato; Takahiro Nakazawa; Shuya Shimizu; Atsuyuki Hirano; Fumihiro Okumura; Tomoaki Ando; Hitoshi Sano; Hiroki Takada; Shozo Togawa; Takashi Joh
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

10.  Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer.

Authors:  Yoshitaka Honma; Yasuhiro Shimada; Atsuo Takashima; Satoru Iwasa; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada; Hirokazu Taniguchi; Shigeki Sekine; Ryoji Kushima
Journal:  Int J Clin Oncol       Date:  2013-11-12       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.